Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysis-Reference-Cited by-同舟云学术

Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysis

Published:2018-09-19 Issue:11 Volume:48 Page:966-973
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Terashima Takeshi¹,Yamashita Tatsuya¹,Sakai Akito²,Ohta Hajime³,Hinoue Yoshinobu⁴,Toya Daisyu⁵,Kawai Hiroshi⁶,Yonejima Manabu⁷,Urabe Takeshi⁸,Noda Yatsugi⁹,Mizukoshi Eishiro¹,Kaneko Shuichi¹

Affiliation:

1. Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan

2. Department of Internal Medicine (Gastroenterology), Toyama Prefectural Central Hospital, Toyama, Japan

3. Department of Gastroenterology, National Hospital Organization Kanazawa Medical Central Hospital, Kanazawa, Japan

4. Department of Gastroenterology, Toyama City Hospital, Toyama, Japan

5. Department of Internal Medicine, FukuiKen Saiseikai Hospital, Fukui, Japan

6. Department of Gastroenterology, Tonami General Hospital, Tonami, Japan

7. Department of Gastroenterology, Municipal Tsuruga Hospital, Tsuruga, Japan

8. Department of Gastroenterology, Public Central Hospital of Matto-Ishikawa, Hakusan, Japan

9. Department of Internal Medicine, Saiseikai Takaoka Hospital, Takaoka, Japan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/11/966/26180672/hyy132.pdf

Reference22 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Pancreatic cancer;Vincent;Lancet,2011

3. The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence;Fusaroli;Gastrointest Endosc,2016

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cnacer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer;BJC Reports;2024-01-23

2. Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project;Molecular and Clinical Oncology;2023-10-25

3. Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map;Supportive Care in Cancer;2023-01-09

4. Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis;Cancer Control;2023-01-02

5. Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World;Advances in Therapy;2022-10-05